Atlas Trials

Pixantrone as Bridging Therapy to Allogenic Transplant or CAR-T Cell Therapy in DLBCL Patients

Clinical trial NCT06760936 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06760936
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
Diffuse Large B Cell Lymphoma (DLBCL)
Start date
2022-06-06
Primary completion
2025-12-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.